ChinaBio® Research

ChinaBio® Research maintains a team of analysts and researchers in Shanghai and San Diego, performing primary and secondary research on a variety of subjects in China's life science industry:

  • Therapeutics, diagnostics and medical devices
  • Novel technology development in China
  • Government funding activity
  • Clinical trial activity in China
  • VC investment in life science companies
  • M&A/IPO activity
  • Partnering/collaboration deals

Some of our key findings from our 2014 data include:

  • VC investment in China life science reached a record $1.7B
  • Corporate investment jumped 7-fold to $1.5B
  • M&A had a 5th straight record year at $8.6B, a 66% increase
  • Partnering deals increased nearly 10 fold in 3 years to a record of $1.8B in total deal value
  • Cross-border pharma partnering was up for a 5th straight year to 76 deals, representing 90% of all partnering transactions
  • Biologics deals now represent nearly 1/3 of all partnering deals

Our proprietary databases and research methodologies provide ChinaBio with unique insights into the China life science industry, and are often used in our consulting engagements and commissioned reports (see Consulting).

ChinaBio also publishes the most widely read newsletter on China's life science industry, ChinaBio® Today.

Please contact us if you would like more information on our research activities, databases, newsletters or reports.

Free Newsletter

ChinaBio® Today
Email address: